Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections.

Authors

Emery Haley
Natalie Luke
Howard Korman, Beaumont Health
David Baunoch
Dakun Wang
Xinhua Zhao
Mohit Mathur

Document Type

Article

Publication Date

9-26-2023

Publication Title

Diagnostics (Basel)

Abstract

This study compared rates of empirical-therapy use and negative patient outcomes between complicated and recurrent urinary tract infection (r/cUTI) cases diagnosed with a multiplex polymerase chain reaction or pooled antibiotic susceptibility testing (M-PCR/P-AST) vs. standard urine culture (SUC). Subjects were 577 symptomatic adults (

Volume

13

Issue

19

First Page

3060

Recommended Citation

Haley E, Luke N, Korman H, Baunoch D, Wang D, Zhao X, et al Improving patient outcomes while reducing empirical treatment with multiplex-polymerase-chain-reaction/pooled-antibiotic-susceptibility-testing assay for complicated and recurrent urinary tract infections. Diagnostics (Basel). 2023 Sep 26;13(19):3060. doi: 10.3390/diagnostics13193060. PMID: 37835804

DOI

10.3390/diagnostics13193060

ISSN

2075-4418

PubMed ID

37835804